Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Obstetrics and Gynecology, Sahmyook Medical Center, Seoul, Korea.
Mol Oncol. 2021 Apr;15(4):987-1004. doi: 10.1002/1878-0261.12884. Epub 2021 Jan 7.
Ovarian clear cell carcinoma (OCCC) reportedly develops from endometriosis. However, the molecular mechanism underlying its malignant progression to OCCC remains elusive. This study aimed to identify an essential gene in the malignant transformation of endometriosis to OCCC. We performed RNA sequencing in formalin-fixed, paraffin-embedded (FFPE) tissues of endometriosis (n = 9), atypical endometriosis (AtyEm) (n = 18), adjacent endometriosis to OCCC (AdjEm) (n = 7), and OCCC (n = 17). We found that tetraspanin 1 (TSPAN1) mRNA level was significantly increased by 2.4- (DESeq2) and 3.4-fold (edgeR) in AtyEm and by 80.7- (DESeq2) and 101-fold (edgeR) in OCCC relative to endometriosis. We confirmed that TSPAN1 protein level was similarly overexpressed in OCCC tissues and cell lines. In immortalized endometriosis cell lines, TSPAN1 overexpression enhanced cell growth and invasion. Mechanistically, TSPAN1 triggered AMP-activated protein kinase (AMPK) activity, promoting endometriosis and cell growth. Upregulated levels of TSPAN1 are considered an early event in the development of high-risk endometriosis that could progress to ovarian cancer. Our study suggests the potential of TSPAN1 as a screening candidate for high-risk endometriosis.
卵巢透明细胞癌(OCCC)据报道来源于子宫内膜异位症。然而,其向 OCCC 恶性进展的分子机制仍不清楚。本研究旨在鉴定子宫内膜异位症向 OCCC 恶性转化过程中的关键基因。我们对福尔马林固定、石蜡包埋(FFPE)的子宫内膜异位症(n=9)、非典型子宫内膜异位症(AtyEm)(n=18)、OCCC 旁子宫内膜异位症(AdjEm)(n=7)和 OCCC(n=17)组织进行了 RNA 测序。我们发现,TSPAN1 mRNA 水平在 AtyEm 中分别上调了 2.4 倍(DESeq2)和 3.4 倍(edgeR),在 OCCC 中上调了 80.7 倍(DESeq2)和 101 倍(edgeR)。我们证实 TSPAN1 蛋白水平在 OCCC 组织和细胞系中也过表达。在永生化子宫内膜异位症细胞系中,TSPAN1 过表达增强了细胞的生长和侵袭能力。机制上,TSPAN1 触发 AMP 激活的蛋白激酶(AMPK)活性,促进了子宫内膜异位症和细胞生长。TSPAN1 的上调水平被认为是发展为高风险子宫内膜异位症并可能进展为卵巢癌的早期事件。我们的研究表明,TSPAN1 有可能成为高风险子宫内膜异位症的筛查候选物。